hexamethylene bisacetamide has been researched along with adenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderson, T | 1 |
| Gazitt, Y | 1 |
1 review(s) available for hexamethylene bisacetamide and adenosine
| Article | Year |
|---|---|
Poly(ADP-ribosylation) processing as a target for the anti-tumor effects of the cell differentiating agent, hexamethylenebisacetamide, and the N6-substituted adenosines.
Topics: Acetamides; Adenosine; Antineoplastic Agents; Cell Differentiation; Humans; Nuclear Proteins; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational | 1991 |
1 other study(ies) available for hexamethylene bisacetamide and adenosine
| Article | Year |
|---|---|
Inhibition of induced L-ornithine decarboxylase stimulation and erythrodifferentiation in Friend erythroleukemia cells by 2',5'-isoadenylate trimer core.
Topics: Acetamides; Adenosine; Animals; Carboxy-Lyases; Cell Differentiation; Cell Line; Diamines; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Leukemia, Erythroblastic, Acute; Neoplasms, Experimental; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors | 1981 |